Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
FOLD (NASDAQ: FOLD)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Amicus Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Nov 12, 2009 08:01 AM |
FOLD
Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors
Nov 03, 2009 08:02 AM |
APD
,
FOLD
,
MRK
Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston
Nov 02, 2009 09:01 AM |
BMY
,
FOLD
,
GENZ
,
PFWD
Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
Oct 29, 2009 04:06 PM |
FOLD
,
SHPGY
Amicus Therapeutics Announces Third Quarter 2009 Financial Results Release Date
Oct 26, 2009 08:02 AM |
FOLD
Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Oct 02, 2009 04:06 PM |
FOLD
,
SHPGY
Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
Sep 30, 2009 08:02 AM |
FOLD
Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14, 2009
Sep 10, 2009 08:01 AM |
FOLD
,
MS
FDA Calendar Updates: EURX, AMGN, FOLD, ONTY, MEDX
Jun 22, 2009 08:19 PM |
AMGN
,
BMY
,
EURX
,
FOLD
,
MEDX
,
ONTY
10 Extreme Trades On Pending Clinical Trial Results
May 14, 2009 11:42 AM |
ARNA
,
CLDA
,
FOLD
,
GNTA
,
INSM
,
JAZZ
More..
How Goldman Secretly Bet on the Housing Crash
Nov 01, 2009 01:54 PM |
AIG
,
BLUE
,
FOLD
,
GOT
,
GS
,
MCO
How Goldman Secretly Bet on the Housing Crash
Nov 01, 2009 03:52 AM |
AIG
,
BLUE
,
FOLD
,
GOT
,
GS
,
MCO
More..
Cylex, Inc. Appoints Brad L. Stewart As Chief Executive Officer and Chairman of the Board
Sep 10, 2009 09:58 AM |
DXCM
,
FOLD
,
WYE
StockPreacher.Com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.
Aug 10, 2009 07:51 AM |
AMGN
,
BAX
,
FOLD
,
GENZ
,
KERX
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
Aug 05, 2009 04:00 PM |
FOLD
Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
Jul 29, 2009 08:01 AM |
FOLD
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
Jun 22, 2009 08:02 AM |
FOLD
Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
May 11, 2009 08:02 AM |
FOLD
Amicus Therapeutics Announces First Quarter 2009 Financial Results
May 07, 2009 04:01 PM |
FOLD
Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
Apr 30, 2009 08:02 AM |
FOLD
Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
Mar 30, 2009 08:00 AM |
FOLD
Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
Mar 28, 2009 07:15 AM |
FOLD
More..
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: John McAdam M (10K)
Nov 17, 2009 05:19 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Kirk John (10K)
Nov 17, 2009 05:16 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Campbell Bradley L (10K)
Nov 17, 2009 05:14 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Gilmore Geoffrey (10K)
Nov 17, 2009 05:12 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Schaeffer Orlov S Nicole (10K)
Nov 17, 2009 05:09 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Boudes Pol F (10K)
Nov 17, 2009 05:07 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Lockhart David J (10K)
Nov 17, 2009 05:05 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Patterson Matthew R (10K)
Nov 17, 2009 05:01 PM
Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Crowley John F (10K)
Nov 17, 2009 05:00 PM
Form 3 MCGLYNN MARGARET G For: Oct 28 (10K)
Nov 06, 2009 10:47 AM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
FOLD
Compare to S&P
YTD
-49.75 %
-58.49 %
4 Weeks
-10.49 %
-10.97 %
12 Weeks
-61.11 %
-63.50 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
1.67 %
EPS Growth in Last Year:
-63.89 %
Sales Growth in Last Quarter:
-8.36 %
Sales Growth in Last Quarter:
34.49 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
